Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.37 |
| ▸ | AKR1C4 | P17516 | 2/20 | 0.36 |
| ▸ | AKR1C3 | P42330 | 2/20 | 0.36 |
| ▸ | AKR1C2 | P52895 | 2/20 | 0.36 |
| ▸ | AKR1C1 | Q04828 | 2/20 | 0.36 |
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.36 |
| ▸ | ESR1 | P03372 | 1/20 | 0.35 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.35 |
| ▸ | GLA | P06280 | 1/20 | 0.35 |
| ▸ | CA12 | O43570 | 2/20 | 0.34 |
| ▸ | CA1 | P00915 | 2/20 | 0.34 |
| ▸ | CA2 | P00918 | 2/20 | 0.34 |
| ▸ | TSHR | P16473 | 2/20 | 0.34 |
| ▸ | CA7 | P43166 | 2/20 | 0.34 |
| ▸ | CA9 | Q16790 | 2/20 | 0.34 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27725966 | 0.95 | CYP1A2 (0.50) | CYP1A2KDM4EAKR1C4AKR1C3AKR1C2 | |
| SCHEMBL148218 | 0.94 | CYP1A2 (0.54) | CYP1A2KDM4EAKR1C4AKR1C3AKR1C2 | |
| SCHEMBL31336416 | 0.90 | CYP1A2 (0.45) | CYP1A2KDM4EAKR1C4AKR1C3AKR1C2 | |
| SCHEMBL27752313 | 0.86 | CYP1A2 (0.45) | CYP1A2KDM4EAKR1C4AKR1C3AKR1C2 | |
| SCHEMBL31202812 | 0.86 | CYP1A2 (0.45) | CYP1A2KDM4EAKR1C4AKR1C3AKR1C2 | |
| SCHEMBL4274148 | 0.85 | CYP1A2 (0.44) | CYP1A2KDM4EAKR1C4AKR1C3AKR1C2 | |
| SCHEMBL21752119 | 0.85 | CYP1A2 (0.44) | CYP1A2KDM4EAKR1C4AKR1C3AKR1C2 | |
| SCHEMBL31336516 | 0.85 | CYP1A2 (0.44) | CYP1A2KDM4EAKR1C4AKR1C3AKR1C2 | |
| SCHEMBL30621714 | 0.85 | CYP1A2 (0.44) | CYP1A2KDM4EAKR1C4AKR1C3AKR1C2 | |
| SCHEMBL16588884 | 0.85 | CYP1A2 (0.40) | CYP1A2KDM4EMEN1KMT2ARXFP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190352511-A1 | LANTHANIDE COMPLEXES COMPRISING DENDRIMERS | UNIVERSITE D'ORLEANS (FR) | 2019-11-21 | — | — | US | disclosed |
| EP-3568401-A1 | LANTHANIDE COMPLEXES COMPRISING DENDRIMERS | Universite D'Orleans (FR) | 2019-11-20 | — | — | EP | disclosed |
| EP-2240970-B1 | PERYLENE SEMICONDUCTORS AND METHODS OF PREPARATION AND USE THEREOF | BASF SE (DE) | 2018-03-14 | — | — | EP | disclosed |
| EP-2683718-B1 | THIOCYANATO SUBSTITUTED NAPHTHALENE DIIMIDE COMPOUNDS AND THEIR USE AS N-TYPE SEMICONDUCTORS | BASF SE (DE) | 2017-05-24 | — | — | EP | disclosed |
| US-8710225-B2 | Thiocyanato or isothiocyanato substituted naphthalene diimide and rylene diimide compounds and their use as n-type semiconductors | BASF SE (DE) | 2014-04-29 | — | — | US | disclosed |
| US-20130289279-A1 | THIOCYANATO OR ISOTHIOCYANATO SUBSTITUTED NAPHTHALENE DIIMIDE AND RYLENE DIIMIDE COMPOUNDS AND THEIR USE AS N-TYPE SEMICONDUCTORS | BASF SE (DE) | 2013-10-31 | — | — | US | disclosed |
| US-8404844-B2 | Perylene semiconductors and methods of preparation and use thereof | BASF SE (DE) | 2013-03-26 | — | — | US | disclosed |
| US-20100319778-A1 | PERYLENE SEMICONDUCTORS AND METHODS OF PREPARATION AND USE THEREOF | BASF SE (DE) | 2010-12-23 | — | — | US | disclosed |
| EP-2240970-A1 | PERYLENE SEMICONDUCTORS AND METHODS OF PREPARATION AND USE THEREOF | BASF SE (DE) | 2010-10-20 | — | — | EP | disclosed |
| WO-2009098252-A1 | PERYLENE SEMICONDUCTORS AND METHODS OF PREPARATION AND USE THEREOF | BASF SE (DE) | 2009-08-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190352511-A1 | LANTHANIDE COMPLEXES COMPRISING DENDRIMERS | CLTA, CLTB, CA12 | CYP1A2 2528/4885KDM4E 3267/4885AKR1C4 1611/4885 |
| US-20100319778-A1 | PERYLENE SEMICONDUCTORS AND METHODS OF PREPARATION AND USE THEREOF | CDYL, PNN, CPNE4 | CYP1A2 463/4885KDM4E 1742/4885AKR1C4 4337/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.